AXIOGENES Stock

Stocks

End-of-day quote Xetra
- ^EUR	-

14/07/15	Axiogenes : s : Signs Sublicensing Agreement for Cellular Assay Patents with GE Healthcare.	BU
04/12/12	AXIOGENES : Axiogenesis Earns U.S. Patent with In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy	BU
10/10/11	AXIOGENES : At Last, a Cardiomyopathy Disease Model: Axiogenesis Has Been Granted a Far-Reaching Patent in Europe	BU

17/07/15

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+0.56%	-4.17%	-1.90%	+9.79%	45.63B
REVOLUTION MEDICINES, INC.	-0.12%	-1.19%	+343.42%	+545.03%	43.96B
IQVIA HOLDINGS INC.	+1.51%	+4.04%	+45.01%	+27.38%	43.73B
BEONE MEDICINES AG	-2.07%	-1.42%	+4.28%	+72.97%	40.23B
CELLTRION, INC.	-0.73%	-4.72%	+8.55%	+37.89%	31.86B
ASCENDIS PHARMA A/S	-9.49%	-11.23%	-	-	17.4B
MEDPACE HOLDINGS, INC.	+4.21%	+5.01%	+24.99%	+121.62%	16.62B
EUROFINS SCIENTIFIC SE	+1.83%	+2.63%	+15.14%	+33.31%	14.46B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.08%	-2.81%	+79.24%	+31.27%	13.04B
Average	-0.50%	-1.81%	+64.84%	+109.91%	29.66B
Weighted average by Cap.	-0.36%	-2.09%	+76.51%	+130.88%